tyrosyl-isoleucyl-glycyl-seryl-arginine and Urinary Bladder Neoplasms

tyrosyl-isoleucyl-glycyl-seryl-arginine has been researched along with Urinary Bladder Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gordon, CS; Hyacinthe, LM; Jarrett, TW; Vaughan, ED; Whalen, GF	1

Other Studies

1 other study(ies) available for tyrosyl-isoleucyl-glycyl-seryl-arginine and Urinary Bladder Neoplasms

Article	Year
Inhibition of bladder tumor cell implantation in cauterized urothelium, without inhibition of healing, by a fibronectin-related peptide (GRGDS). Annals of surgical oncology, 1995, Volume: 2, Issue:5 Topics: Animals; Antineoplastic Agents; Cautery; Cell Adhesion; Epithelium; Extracellular Matrix; Female; Heparin; Mannose; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Oligopeptides; Urinary Bladder; Urinary Bladder Neoplasms; Wound Healing	1995

Article

Year

Inhibition of bladder tumor cell implantation in cauterized urothelium, without inhibition of healing, by a fibronectin-related peptide (GRGDS).

Annals of surgical oncology, 1995, Volume: 2, Issue:5

Topics: Animals; Antineoplastic Agents; Cautery; Cell Adhesion; Epithelium; Extracellular Matrix; Female; Heparin; Mannose; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Oligopeptides; Urinary Bladder; Urinary Bladder Neoplasms; Wound Healing

1995